Affiliation:
1. Department of Stem Cell and Regenerative Biology, and Center for Brain Science, Harvard University
2. Gladstone Institute of Data Science and Biotechnology
3. Molecular Neurobiology Laboratory, Salk Institute for Biological Studies
4. Institute for Pediatric Regenerative Medicine, Shriners Hospitals for Children, Northern California, University of California-Davis
5. Koc University, Translational Medicine Research Center, KUTTAM-NDAL
Abstract
Corticospinal neurons (CSN) centrally degenerate in amyotrophic lateral sclerosis (ALS), along with spinal motor neurons, and loss of voluntary motor function in spinal cord injury (SCI) results from damage to CSN axons. For functional regeneration of specifically affected neuronal circuitry
in vivo
, or for optimally informative disease modeling and/or therapeutic screening
in vitro
, it is important to reproduce the type or subtype of neurons involved. No such appropriate
in vitro
models exist with which to investigate CSN selective vulnerability and degeneration in ALS, or to investigate routes to regeneration of CSN circuitry for ALS or SCI, critically limiting the relevance of much research. Here, we identify that the HMG-domain transcription factor
Sox6
is expressed by a subset of NG2+ endogenous cortical progenitors in postnatal and adult cortex, and that
Sox6
suppresses a latent neurogenic program by repressing inappropriate proneural
Neurog2
expression by progenitors. We FACS-purify these genetically accessible progenitors from postnatal mouse cortex and establish a pure culture system to investigate their potential for directed differentiation into CSN. We then employ a multi-component construct with complementary and differentiation-sharpening transcriptional controls (activating
Neurog2, Fezf2
, while antagonizing
Olig2
with
VP16:Olig2
). We generate corticospinal-like neurons from SOX6+/NG2+ cortical progenitors, and find that these neurons differentiate with remarkable fidelity compared with corticospinal neurons
in vivo
. They possess appropriate morphological, molecular, transcriptomic, and electrophysiological characteristics, without characteristics of the alternate intracortical or other neuronal subtypes. We identify that these critical specifics of differentiation are not reproduced by commonly employed
Neurog2
-driven differentiation. Neurons induced by
Neurog2
instead exhibit aberrant multi-axon morphology and express molecular hallmarks of alternate cortical projection subtypes, often in mixed form. Together, this developmentally-based directed differentiation from genetically accessible cortical progenitors sets a precedent and foundation for
in vitro
mechanistic and therapeutic disease modeling, and toward regenerative neuronal repopulation and circuit repair.
Publisher
eLife Sciences Publications, Ltd